×î×¼µÄÁùºÏ²ÊÂÛ̳

XClose

Early Phase Cancer Trials Programme at ×î×¼µÄÁùºÏ²ÊÂÛ̳ and ×î×¼µÄÁùºÏ²ÊÂÛ̳H

Home
Menu

Breast Trials

A LIST OF OUR EARLY PHASE Breast cancerÌýTRIALS WHICH ARE OPEN TO RECRUITMENT AT UNIVERSITY COLLEGE LONDON HOSPITALs

To find more information on ×î×¼µÄÁùºÏ²ÊÂÛ̳H Early Phase Cancer Clinical Trials, including eligibility criteria, click theÌýhyperlinkedÌýLocal Project Reference (LRP)ÌýID, which will take you to the ×î×¼µÄÁùºÏ²ÊÂÛ̳H Find a Study database.

Ìý

ELEVATE

A Phase 1b/2, Open-label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE)

Local Project Reference:158415
Principal InvestigatorDr Rebecca Roylance
Drug Class/ Treatment:

Elacestrant (Estrogen Receptor Antangonist) + Various Combination

Patient Population:ER+, HER2– Breast Cancer
Trial Hosted By - NIHR ×î×¼µÄÁùºÏ²ÊÂÛ̳H Clinical Research Facility (CRF)

ELECTRA (ELA-0121)

A Phase 2 Study of Magrolimab Combination Therapy in ÌýPatients With Unresectable, Locally Advanced or Metastatic

Local Project Reference:
Principal InvestigatorDr Elisavet Papadimitraki
Drug Class/ Treatment:

Elacestrant (Oral selective ER degrader)

Patient Population:

Women and men with brain metastasis from estrogen receptor positive, her-2 negative breast cancer

Trial Hosted By - NIHR ×î×¼µÄÁùºÏ²ÊÂÛ̳H Clinical Research Facility (CRF)

Ìý

Ìý